Gyre Therapeutics Inc XNAS: GYRE

Expensive Performer

Download real time

7.69 0.11 (1.45%)

59.53% Fall from 52W High

55,662

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Gyre Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents